Lupus Anticoagulant

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

Lupus Anticoagulant

Test Information:
LA 1 Screening Reagent and LA 2 Confirmation Reagent are simplified DRVVT reagents for the detection of Lupus Anticoagulant (LA) in one-stage clotting tests. They occur in various clinical conditions, especially autoimmune diseases and are now considered to be a significant risk factor in patients with otherwise unexplained thrombosis and are often present in women who have recurrent fetal loss.

Specimen Container:
Blue Top Tube (Sodium Citrate)

Specimen Type:
Plasma

Required Volume:
2 mL

Patient Preparation:
No Patient Preparation

Notes:
To obtain optimal results, it is recommended to separate plasma from whole blood within 15 minutes from the time of collection; aliquoted specimen must be transported within 4 hours from the time of collection.
For aliquoted specimen, DO NOT USE GLASS TUBE CONTAINER.

  • However, if delay in transportation occurs, it is vital to follow the stipulated storage and stability. Specimen received beyond the stipulated storage and stability is considered “sub-optimal” in nature.
  • For FROZEN specimen, send specimen on running day prior to cut-off period ; ONE TIME THAWING ONLY!

Storage & Stability
(Before Processing)

  • Storage: 2 to 8°C
    Stability: 4 hours
  • Storage: – 20°C
    Stability: 1 week

Transport Temperature:
Freshly collected specimen:
Ref (2°C to 8°C)
Frozen specimen: Frozen (- 20°C)

Test Category:
Batch

Test Schedule:
Specimen receiving CUT-OFF:
Tuesday and Friday, 1100H

All specimen received beyond cut-off will be included for the next batch processing.

Results Availability:
Wednesday and Saturday at 1200H

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.